Opinion | Why Is Boston’s Biotech Industry Struggling?
(feeds.content.dowjones.io)
91.
92.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)
93.
AbbVie Near Deal for Revolution Medicines
(feeds.content.dowjones.io)
94.
PhDs Can't Find Work as Boston's Biotech Engine Sputters
(slashdot.org)
95.
Ph.D.s Can’t Find Work as Boston’s Biotech Engine Sputters
(feeds.content.dowjones.io)
96.
Pfizer ended up passing on my GLP-1 work back in the early '90s (2024)
(news.ycombinator.com)
97.
Startup Lifordi Seeks to Deliver Potent Medication for Autoimmune Diseases
(feeds.content.dowjones.io)
98.
The 9 top biotech startups from Disrupt Startup Battlefield
(techcrunch.com)
99.
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
(feeds.content.dowjones.io)
100.
Take our quiz on the year in health and biotechnology
(technologyreview.com)
101.
102.
Turmoil at the FDA Threatens Biotech Recovery
(feeds.content.dowjones.io)
103.
Johnson & Johnson to Buy Halda Therapeutics For $3.05 Billion
(feeds.content.dowjones.io)
104.
Goldman Sachs asks in biotech Report: Is curing patients a sustainable business?
(news.ycombinator.com)
105.
106.
107.
108.
110.